{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:07:56Z","timestamp":1790518076752,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1124\/jpet.119.259663","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:15:18Z","timestamp":1560374118000},"page":"219-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy"],"prefix":"10.1016","volume":"370","author":[{"given":"Jonathan","family":"Oliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Galasinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Richey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Wen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi","family":"Tawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Tapscott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Sverdrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.259663_bib1","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1242\/jeb.205.16.2387","article-title":"\u03b11- and \u03b2-adrenoceptor stimulation differentially activate p38-MAPK and atrial natriuretic peptide production in the perfused amphibian heart","volume":"205","author":"Aggeli","year":"2002","journal-title":"J Exp Biol"},{"key":"10.1124\/jpet.119.259663_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.191.5.859","article-title":"Deficiency of the stress kinase p38\u03b1 results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells","volume":"191","author":"Allen","year":"2000","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.119.259663_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/15592294.2015.1113798","article-title":"Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4 [published correction appears in Epigenetics (2016) 11:175]","volume":"10","author":"Balog","year":"2015","journal-title":"Epigenetics"},{"key":"10.1124\/jpet.119.259663_bib4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/hmg\/ddy405","article-title":"Dynamic transcriptomic analysis reveals suppression of PGC1\u03b1\/ERR\u03b1 drives perturbed myogenesis in facioscapulohumeral muscular dystrophy","volume":"28","author":"Banerji","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(02)00481-1","article-title":"Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression","volume":"9","author":"Bergstrom","year":"2002","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.119.259663_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nm.3465","article-title":"p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice","volume":"20","author":"Bernet","year":"2014","journal-title":"Nat Med"},{"key":"10.1124\/jpet.119.259663_bib7","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1093\/hmg\/ddt314","article-title":"Wnt\/\u03b2-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells","volume":"22","author":"Block","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib8","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","article-title":"An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies","volume":"27","author":"Bosnakovski","year":"2008","journal-title":"EMBO J"},{"key":"10.1124\/jpet.119.259663_bib9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/stem.1399","article-title":"p38\u03b1 MAPK regulates adult muscle stem cell fate by restricting progenitor proliferation during postnatal growth and repair","volume":"31","author":"Brien","year":"2013","journal-title":"Stem Cells"},{"key":"10.1124\/jpet.119.259663_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/nar\/26.2.486","article-title":"Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate\/early promoter","volume":"26","author":"Bruening","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.119.259663_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","article-title":"BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells","volume":"7","author":"Campbell","year":"2017","journal-title":"Skelet Muscle"},{"key":"10.1124\/jpet.119.259663_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13395-016-0100-z","article-title":"p38\u03b1 MAPK disables KMT1A-mediated repression of myogenic differentiation program","volume":"6","author":"Chatterjee","year":"2016","journal-title":"Skelet Muscle"},{"key":"10.1124\/jpet.119.259663_bib13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/mt.2016.111","article-title":"Morpholino-mediated knockdown of DUX4 toward facioscapulohumeral muscular dystrophy therapeutics","volume":"24","author":"Chen","year":"2016","journal-title":"Mol Ther"},{"key":"10.1124\/jpet.119.259663_bib14","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1093\/nar\/gkw141","article-title":"DUX4 recruits p300\/CBP through its C-terminus and induces global H3K27 acetylation changes","volume":"44","author":"Choi","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.119.259663_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/519311","article-title":"Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy","volume":"81","author":"Clapp","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1124\/jpet.119.259663_bib16","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1074\/jbc.RA118.002633","article-title":"Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy","volume":"293","author":"Cruz","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.259663_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem J"},{"key":"10.1124\/jpet.119.259663_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.119.259663_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160022","article-title":"Influence of repressive histone and DNA methylation upon D4Z4 transcription in non-myogenic cells","volume":"11","author":"Das","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.259663_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2015.08.007","article-title":"Genetic and epigenetic contributors to FSHD","volume":"33","author":"Daxinger","year":"2015","journal-title":"Curr Opin Genet Dev"},{"key":"10.1124\/jpet.119.259663_bib21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1124\/jpet.119.259663_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.3858","article-title":"DUX-family transcription factors regulate zygotic genome activation in placental mammals","volume":"49","author":"De Iaco","year":"2017","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.119.259663_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jcsm.12145","article-title":"Activin A induces skeletal muscle catabolism via p38\u03b2 mitogen-activated protein kinase","volume":"8","author":"Ding","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1124\/jpet.119.259663_bib24","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/npjregenmed.2016.6","article-title":"Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy","volume":"1","author":"Dumont","year":"2016","journal-title":"NPJ Regen Med"},{"key":"10.1124\/jpet.119.259663_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04996","article-title":"A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy","volume":"4","author":"Feng","year":"2015","journal-title":"eLife"},{"key":"10.1124\/jpet.119.259663_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194197","article-title":"The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: a randomised double-blind placebo-controlled trial","volume":"13","author":"Fisk","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.259663_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev Cell"},{"key":"10.1124\/jpet.119.259663_bib28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/1568026054985939","article-title":"Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development","volume":"5","author":"Goldstein","year":"2005","journal-title":"Curr Top Med Chem"},{"issue":"12","key":"10.1124\/jpet.119.259663_bibib90","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.nmd.2017.09.007","article-title":"Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data","volume":"27","author":"Goselink","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1124\/jpet.119.259663_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147198","article-title":"Comparative study of injury models for studying muscle regeneration in mice","volume":"11","author":"Hardy","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.259663_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.119.259663_bib31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/jpet.108.139006","article-title":"Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity","volume":"327","author":"Hill","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259663_bib32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1089\/ars.2014.6090","article-title":"Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease","volume":"22","author":"Himeda","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.119.259663_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/cpdd.190","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of losmapimod in healthy Japanese volunteers","volume":"4","author":"Ino","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1124\/jpet.119.259663_bib34","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.biocel.2013.06.025","article-title":"\u03b22-Adrenergic agonists and the treatment of skeletal muscle wasting disorders","volume":"45","author":"Joassard","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/jpet.119.259663_bib35","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1093\/hmg\/dds284","article-title":"Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis","volume":"21","author":"Jones","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib36","doi-asserted-by":"crossref","first-page":"29881","DOI":"10.1038\/srep29881","article-title":"Comparative chemical array screening for p38\u03b3\/\u03b4 MAPK inhibitors using a single gatekeeper residue difference between p38\u03b1\/\u03b2 and p38\u03b3\/\u03b4","volume":"6","author":"Kondoh","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.259663_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1124\/jpet.119.259663_bib38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ajpath.2012.07.007","article-title":"Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD","volume":"181","author":"Krom","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.119.259663_bib39","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1074\/jbc.M414221200","article-title":"BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo","volume":"280","author":"Kuma","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.259663_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","article-title":"p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases","volume":"2","author":"Kumar","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.119.259663_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.1997.6849","article-title":"Novel homologues of CSBP\/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles","volume":"235","author":"Kumar","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.119.259663_bib42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"10.1124\/jpet.119.259663_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00412-012-0380-y","article-title":"Evolution of DUX gene macrosatellites in placental mammals","volume":"121","author":"Leidenroth","year":"2012","journal-title":"Chromosoma"},{"key":"10.1124\/jpet.119.259663_bib44","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.119.259663_bib45","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1124\/jpet.119.259663_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/jpet.119.259663_bib47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/MCB.01466-08","article-title":"Hematopoietic protein tyrosine phosphatase mediates \u03b22-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes","volume":"29","author":"McAlees","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.119.259663_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0014-5793(98)01392-1","article-title":"The activation of p38 MAPK by the \u03b2-adrenergic agonist isoproterenol in rat epididymal fat cells","volume":"439","author":"Moule","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.119.259663_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.110.166173","article-title":"A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor \u03b1 production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation","volume":"333","author":"Mourey","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259663_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/13543784.2015.1006358","article-title":"Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease","volume":"24","author":"Norman","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/jpet.119.259663_bib51","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2016.3609","article-title":"Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial","volume":"315","author":"O\u2019Donoghue","year":"2016","journal-title":"JAMA"},{"key":"10.1124\/jpet.119.259663_bib52","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/mus.880181315","article-title":"Facioscapulohumeral muscular dystrophy in the Dutch population","volume":"2","author":"Padberg","year":"1995","journal-title":"Muscle Nerve Suppl"},{"key":"10.1124\/jpet.119.259663_bib53","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/art.27631","article-title":"Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?","volume":"62","author":"Page","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.119.259663_bib54","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1101\/gad.1234304","article-title":"A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation","volume":"18","author":"Penn","year":"2004","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.119.259663_bib55","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.emboj.7601587","article-title":"Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38\u03b1 in abrogating myoblast proliferation","volume":"26","author":"Perdiguero","year":"2007","journal-title":"EMBO J"},{"key":"10.1124\/jpet.119.259663_bib56","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nsmb1316","article-title":"p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation","volume":"14","author":"Rampalli","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/jpet.119.259663_bib57","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/acs.jmedchem.7b01795","article-title":"Structure-based design of pyridone\u2013aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1\/2) inhibition","volume":"61","author":"Reich","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259663_bib58","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","article-title":"Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways","volume":"24","author":"Rickard","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib59","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.4161\/cc.7.14.6273","article-title":"Efficient adult skeletal muscle regeneration in mice deficient in p38\u03b2, p38\u03b3 and p38\u03b4 MAP kinases","volume":"7","author":"Ruiz-Bonilla","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1124\/jpet.119.259663_bib60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13395-016-0078-6","article-title":"Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts","volume":"6","author":"Sakellariou","year":"2016","journal-title":"Skelet Muscle"},{"key":"10.1124\/jpet.119.259663_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13395-016-0074-x","article-title":"Chromatin-wide and transcriptome profiling integration uncovers p38\u03b1 MAPK as a global regulator of skeletal muscle differentiation","volume":"6","author":"Segal\u00e9s","year":"2016","journal-title":"Skelet Muscle"},{"key":"10.1124\/jpet.119.259663_bib62","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1016\/j.bmcl.2011.04.121","article-title":"Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase","volume":"21","author":"Selness","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.119.259663_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006658","article-title":"DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy","volume":"13","author":"Shadle","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1124\/jpet.119.259663_bib64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3727\/000000005783982837","article-title":"Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation","volume":"14","author":"Silva-Barbosa","year":"2005","journal-title":"Cell Transplant"},{"key":"10.1124\/jpet.119.259663_bib65","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ng1378","article-title":"p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci","volume":"36","author":"Simone","year":"2004","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.119.259663_bib66","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/hmg\/ddp180","article-title":"RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy","volume":"18","author":"Snider","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1124\/jpet.119.259663_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2044-5040-1-12","article-title":"Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population","volume":"1","author":"Stadler","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1124\/jpet.119.259663_bib69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","article-title":"DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?","volume":"17","author":"Tassin","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.119.259663_bib70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2044-5040-4-12","article-title":"Facioscapulohumeral dystrophy: the path to consensus on pathophysiology","volume":"4","author":"Tawil","year":"2014","journal-title":"Skelet Muscle"},{"key":"10.1124\/jpet.119.259663_bib71","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1172\/JCI89401","article-title":"Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity","volume":"127","author":"Teveroni","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.119.259663_bib72","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.stem.2012.05.025","article-title":"Coordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38\u03b1\/\u03b2 MAPK","volume":"11","author":"Troy","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1124\/jpet.119.259663_bib73","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1124\/jpet.119.259663_bib74","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"van Overveld","year":"2003","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.119.259663_bib75","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22275","article-title":"DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo","volume":"69","author":"Wallace","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.119.259663_bib76","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1091\/mbc.e07-08-0817","article-title":"Involvement of the p38 mitogen-activated protein kinase \u03b1, \u03b2, and \u03b3 isoforms in myogenic differentiation","volume":"19","author":"Wang","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1124\/jpet.119.259663_bib77","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ng.3846","article-title":"Conservation and innovation in the DUX4-family gene network","volume":"49","author":"Whiddon","year":"2017","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.119.259663_bib78","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/jpet.109.154443","article-title":"Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease","volume":"330","author":"Willette","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259663_bib79","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1093\/hmg\/ddg327","article-title":"Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation","volume":"12","author":"Winokur","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib80","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1128\/MCB.20.11.3951-3964.2000","article-title":"p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps","volume":"20","author":"Wu","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.119.259663_bib81","first-page":"24","article-title":"Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases","volume":"4","author":"Xing","year":"2015","journal-title":"MAP Kinase"},{"key":"10.1124\/jpet.119.259663_bib82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cmdc.201100439","article-title":"Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate","volume":"7","author":"Xing","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1124\/jpet.119.259663_bib83","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.119.259663_bib84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ebiom.2018.01.017","article-title":"Losmapimod overcomes gefitinib resistance in non-small cell lung cancer by preventing tetraploidization","volume":"28","author":"Yeung","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1124\/jpet.119.259663_bib85","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1517\/13543780903321490","article-title":"The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer","volume":"18","author":"Yong","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/jpet.119.259663_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003947","article-title":"DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis","volume":"9","author":"Young","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1124\/jpet.119.259663_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000559","article-title":"Specific loss of histone H3 lysine 9 trimethylation and HP1\u03b3\/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD)","volume":"5","author":"Zeng","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1124\/jpet.119.259663_bib88","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1074\/jbc.274.8.5193","article-title":"p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the MEF2C transcription factor","volume":"274","author":"Zetser","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.259663_bib89","doi-asserted-by":"crossref","first-page":"40635","DOI":"10.1074\/jbc.M006325200","article-title":"\u03b22-Adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or G\u03b2\u03b3 in adult mouse cardiomyocytes","volume":"275","author":"Zheng","year":"2000","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.259663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:58:44Z","timestamp":1739962724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524259309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022356524259309"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.259663","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.259663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}